CIK: 0001577524 · Show all filings
Period: Q1 2014 (← Previous) (Next →)
Filing Date: May 15, 2014
Total Value ($000): $290,423 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARIAD PHARMACEUTICALS INC | 12,000,000 | $96,720 | 33.3% | $6.82 | — | COM | 04033A100 |
| DGX | QUEST DIAGNOSTICS INC | 775,000 | $44,888 | 15.5% | $46.05 | -8.3% | COM | 74834L100 |
| — | BIO-REFERENCE LABS INC | 1,280,984 | $35,458 | 12.2% | $27.20 | — | COM $.01 NEW | 09057G602 |
| — | IDENIX PHARMACEUTICALS INC | 5,050,100 | $30,452 | 10.5% | $5.98 | — | COM | 45166R204 |
| MRK | MERCK & CO INC NEW | 400,000 | $22,708 | 7.8% | $31.29 | +14.3% | COM | 58933Y105 |
| — | MALLINCKRODT PUB LTD CO | 274,895 | $17,431 | 6.0% | $52.26 | — | SHS | G5785G107 |
| — | VIVUS INC | 2,573,943 | $15,289 | 5.3% | $9.08 | — | COM | 928551100 |
| — | REPROS THERAPEUTICS INC | 560,600 | $9,945 | 3.4% | $18.20 | — | COM NEW | 76028H209 |
| — | AVEO PHARMACEUTICALS | 2,570,759 | $3,843 | 1.3% | $1.84 | — | COM | 053588109 |
| — | LABORATORY CORP AMER HLDGS | 37,824 | $3,715 | 1.3% | $98.22 | — | COM NEW | 50540R409 |
| — | INTRA CELLULAR THERAPIES INC | 126,695 | $2,303 | 0.8% | $18.18 | — | COM | 46116X101 |
| — | ONCONOVA THERAPEUTICS INC | 350,000 | $2,219 | 0.8% | $6.34 | — | COM | 68232V108 |
| ENTA | ENANTA PHARMACEUTICALS INC | 50,000 | $2,000 | 0.7% | $36.32 | 0.0% | COM | 29251M106 |
| — | KINDRED BIOSCIENCES INC | 101,825 | $1,887 | 0.6% | $18.53 | — | COM | 494577109 |
| — | TARGACEPT INC | 329,516 | $1,565 | 0.5% | $4.75 | — | COM | 87611R306 |